Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave
(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons. Read More
| Price | 224.00p on 24-10-2025 at 18:35:12 |
|---|---|
| Change | -2.00p -0.87% |
| Buy | 230.00p |
| Sell | 224.00p |
| Last Trade: | Sell 104.00 at 224.00p |
| Day's Volume: | 12,657 |
| Last Close: | 227.00p |
| Open: | 225.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 224.00p - 225.00p |
| 52wk Range: | 187.50p - 319.00p |
| Market Capitalisation: | £1.92b |
| VWAP: | 225.04573p |
| Shares in Issue: | 859.34m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 104 | 224.00p | Automatic Execution |
16:29:59 - 24-Oct-25 |
| Sell* | 251 | 224.00p | Automatic Execution |
16:29:59 - 24-Oct-25 |
| Buy* | 1 | 228.00p | SI Trade |
15:29:01 - 24-Oct-25 |
| Buy* | 657 | 227.164p | Suspected BUY Trade |
15:10:53 - 24-Oct-25 |
| Sell* | 2,000 | 224.555p | Ordinary |
13:39:26 - 24-Oct-25 |
| Buy* | 2,823 | 225.00p | Automatic Execution |
08:35:41 - 24-Oct-25 |
| Sell* | 397 | 225.00p | Automatic Execution |
08:35:41 - 24-Oct-25 |
| Buy* | 1,494 | 225.00p | Automatic Execution |
08:35:34 - 24-Oct-25 |
| Sell* | 397 | 225.00p | Automatic Execution |
08:35:34 - 24-Oct-25 |
| Buy* | 500 | 225.798p | Ordinary |
08:12:13 - 24-Oct-25 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Oct 2025 7:00 am | RNS-R | HUTCHMED Presents Data at AACR NCI EORTC |
| 21st Oct 2025 9:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 14th Oct 2025 9:30 am | RNS | Appointment of Independent Non-executive Director |
| 13th Oct 2025 7:05 am | RNS-R | Data to be Presented at the 2025 ESMO Congress |
| 2nd Oct 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at ESMO |
| 30th Sep 2025 9:30 am | RNS | Total Voting Rights |
| 12th Sep 2025 7:00 am | RNS-R | HUTCHMED to Present R&D Updates on October 31 2025 |
| 5th Sep 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at CSCO |
| 26th Aug 2025 7:00 am | RNS | Directorate Change |
| 20th Aug 2025 7:00 am | RNS-R | HUTCHMED Completes Enrollment of Phase III Trial |